Intrinsic Value of S&P & Nasdaq Contact Us

Innoviva, Inc. INVA

NASDAQ Global Select

SharesGrow Score
86/100
6/7 Pass
SharesGrow Intrinsic Value
$42.36
+75.1%
Analyst Price Target
$37.67
+55.7%

Innoviva, Inc. (INVA) current share price is $24.19. The gold spot price is $4,808.10 per troy ounce. Using the formula: INVA in gold = $24.19 × 31.1035 ÷ $4,808.10 = 0.1565 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of INVA when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding INVA shares over the measured period.

INVA in US Dollars
Gold in US Dollars
INVA in Gold (grams per share)

Real Wealth Growth Rate

INVA
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{INVA}_{\text{gold}}(t) = \frac{P_{\text{INVA}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{INVA}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{INVA}_{\text{gold}}^{(T)}}{\text{INVA}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{INVA}_\text{gold}^{(0)}$ = initial gold-price, $\text{INVA}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

ARGX
ARGX
argenx SE
$828.35
+2.36%
INCY
INCY
Incyte Corporation
$97.69
+2.24%
APLS
APLS
Apellis Pharmaceuticals, Inc.
$40.85
+0.02%
TERN
TERN
Terns Pharmaceuticals, Inc.
$52.68
+0.13%
FOLD
FOLD
Amicus Therapeutics, Inc.
$14.46
-0.03%
MRTX
MRTX
Mirati Therapeutics, Inc.
$58.70
-0.17%
DNLI
DNLI
Denali Therapeutics Inc.
$20.16
+3.81%
DAWN
DAWN
Day One Biopharmaceuticals, Inc.
$21.46
-0.14%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message